Scientific Writing Services
Precision science.
Expertly written.
Publication-ready.
Mitotics delivers PhD-level scientific and medical writing for pharmaceutical and biotech organizations — from regulatory-grade clinical study reports to high-impact manuscripts and authoritative whitepapers. Every document is grounded in molecular science, aligned to current guidelines, and crafted to move your program forward.
PhD
Lead Writer
DFM
Functional Medicine
15+
Years Research
Onc.
Core Specialty
ICH
Guideline Trained
01
Core Writing Services
Sc.
Scientific & Medical Writing
Primary Service
Rigorous, peer-review–ready scientific content authored by a practicing molecular oncology specialist. We translate complex data into clear, compelling narratives for clinical, commercial, and medical affairs audiences.
- Peer-reviewed journal manuscripts (ICMJE compliant)
- Conference abstracts & poster presentations
- Investigator brochures & patient narratives
- Medical affairs slide decks & briefing documents
- Disease state overviews & MOA summaries
- Scientific newsletters & pipeline summaries
Cs.
Clinical Study Reports
Regulatory Documentation
ICH E3–compliant CSR writing with deep biostatistical fluency and oncology-specific expertise. We produce complete, submission-ready reports that meet FDA, EMA, and global regulatory standards.
- Full CSR authoring (ICH E3 structure)
- Patient narratives & individual subject data
- Integrated summaries of efficacy & safety (ISE/ISS)
- Clinical study protocols & protocol amendments
- Clinical overview & synopsis sections
- QC review of existing CSR documents
Wp.
Whitepapers & Literature Reviews
Thought Leadership
Deep-dive scientific whitepapers and systematic literature reviews that establish scientific credibility, support regulatory strategy, and communicate clinical value to KOLs, investors, and payers.
- Scientific whitepapers (10–30 pages)
- Systematic & narrative literature reviews
- Evidence dossiers & value summaries
- Competitive landscape scientific analyses
- Pipeline positioning documents
- Scientific backgrounders for investor relations
Dr.
Not a Writing Mill
Every document is personally authored and reviewed by Kim Lockheimer, PhD, DFM — a practicing molecular oncology specialist, not a ghostwriter managing a pool of contractors.
Mol.
Deep Science Fluency
Molecular oncology, cell cycle biology, biomarker science, and clinical pharmacology expertise embedded in every document — not paraphrased from your data alone.
Reg.
Regulatory Literacy
ICH E3, E6, E8, and GCP-aligned writing. Familiarity with FDA and EMA submission requirements, GPP3 publication ethics, and CONSORT/STROBE guidelines.
Sp.
Oncology Specialty
Core expertise in solid tumors, hematologic malignancies, targeted therapies, immuno-oncology, and ADCs — the highest-demand specialty in pharma writing today.
02
Retainer Packages
Mitotics operates on a monthly retainer model — ensuring your program has consistent, dedicated writing support without the unpredictability of per-project billing. Retainers secure priority access, dedicated bandwidth, and institutional familiarity with your pipeline, compound, and data.
Most Popular
$3,500 / mo
Billed monthly · 3-month minimum
Up to 20 hrs / month
- 1 primary document per month
- Scientific or medical writing deliverables
- 1 literature review per quarter
- Up to 2 revision rounds per document
- Email support within 48 hours
- Rollover of up to 5 unused hours
Recommended
$7,500 / mo
Billed monthly · 3-month minimum
Up to 45 hrs / month
- CSR authoring included
- 2–3 documents per month
- Mixed deliverable types across services
- Monthly strategy call (60 min)
- Unlimited revision rounds
- 48h priority response
- Quarterly literature review included
- Scientific advisory input on document strategy
Custom rate
Scoped by program · Flexible structure
Dedicated bandwidth
- Full submission package support
- Dedicated primary writer assignment
- ISE / ISS / Clinical Overview authoring
- Cross-functional team integration
- Custom SOW & milestone deliverables
- 24h response SLA available
- Regulatory strategy co-development
- White-label / attribution-flexible options
Add-On Services · Available à la carte or with any retainer
ABS
Abstract Writing
Conference submission–ready abstracts. ASCO, AACR, ASH, ESMO–formatted.
From $650
QC
Document QC & Scientific Review
Expert review of existing documents for scientific accuracy, clarity, and regulatory alignment.
From $250 / document
SLR
Systematic Literature Review
PRISMA-compliant SLRs with protocol development, database search, and full synthesis.
From $3,200
GW
Grant Writing Support
NIH, NCI, DoD, and private foundation grant narrative development and scientific editing.
Custom scope
POD
Scientific Poster Design
Conference poster design with scientific content authoring — ready for print and digital.
From $850
EDU
Medical Education Content
CME-compliant disease state education, MOA narratives, and HCP training materials.
From $1,200
03
Engagement Process
I
Discovery
30-min confidential discovery call. We review your program, data package, target audience, and timeline.
II
Scope
We propose the appropriate retainer tier and document scope. NDA / MSA signed. Data securely transferred.
III
Strategy
Scientific strategy call. We review your data, define key messages, and align on publication or submission strategy.
IV
Authoring
First draft delivered per agreed timeline. Structured revision process with tracked changes and clear version control.
V
Delivery
Final submission-ready document delivered. Ongoing retainer provides continuous support for subsequent deliverables.
04
Scientific Credentials & Therapeutic Coverage
All writing is personally led by Kim Lockheimer, PhD, DFM — a molecular oncology specialist and clinical scientist with deep expertise in cell cycle biology, biomarker science, and translational oncology research.
- PhD — Molecular Oncology / Cell Biology
- DFM — Doctor of Functional Medicine
- Specialist in mitotic inhibitors, DNA repair, and drug resistance mechanisms
- Trained in ICH E3/E6/E8, GCP, CONSORT, STROBE, PRISMA guidelines
- Experience with FDA, EMA, and global regulatory submission formats
- GPP3 (ISMPP) good publication practice adherence
- Biomarker development, companion diagnostics, and precision oncology
- NDA/BLA dossier experience across Phase I–IV programs
- Peer-reviewed publications in molecular and clinical oncology
Therapeutic Area Coverage
- Solid Tumors — Breast, Lung, CRC, Pancreatic, ProstateCore
- Hematologic Malignancies — AML, DLBCL, MyelomaCore
- Targeted Oncology — KRAS, EGFR, HER2, BRAF, RETCore
- Immuno-Oncology — Checkpoint Inhibitors, CAR-T, BispecificsIO
- ADC / Radioligand TherapyEmerging
- Biomarker Science & Companion DiagnosticsCore
- Precision Medicine & GenomicsGenomics
- Hormone-Driven Cancers & EndocrinologySpecialty
- Clinical Pharmacology & Drug MetabolismPK/PD
Mitotics® · Scientific Writing Services · All engagements governed by ND